Sanjivani Paranteral Ltd. Share Price & Stock Analysis

Sanjivani Paranteral Ltd. (BSE: 531569) is a Mumbai, Maharashtra-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹212 Cr, it ranks #2,607 by market cap among the 6,197 Indian listed companies on FinBizNet, and #11 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹171.20 (as of 16 Nov 2026), the share price is 29.8% below its 52-week high of ₹244.00 and 35.9% above its 52-week low of ₹126.00. The share price is down 18.0% over one year and down 10.6% over three months.

Key Metrics

Current Price₹171.20
Market Cap₹212 Cr
BSE Code531569
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio31.1
Return on Equity14.76%
Return on Assets6.73%
52-Week Range₹126.00 – ₹244.00
1-Year Price Change-18.0%
3-Month Price Change-10.6%
Beta (1Y)0.94
Dividend Yield0.00%
HeadquartersMumbai, Maharashtra
Websitewww.sanjivani.co.in

Latest Quarterly Results — Q1 FY27

Revenue₹19 Cr
Net Profit₹2 Cr
Net Margin11.8%
EPS (Basic)₹1.87
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Sanjivani Paranteral Ltd. Quarterly Revenue and Profit Trend

Sanjivani Paranteral Ltd. reported revenue of ₹19 Cr in Q1 FY27, up 8.8% from ₹18 Cr in Q1 FY26 and up 85.2% from ₹11 Cr in Q4 FY26. It posted a net profit of ₹2 Cr for the quarter, against a net profit of ₹2 Cr in Q1 FY26 (up 32.9%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹11 Cr (Q4 FY26) to ₹21 Cr (Q3 FY26). The company was profitable in each of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹19 Cr₹2 Cr11.8%
Q4 FY26₹11 Cr₹1 Cr8.9%
Q3 FY26₹21 Cr₹3 Cr12.6%
Q2 FY26₹16 Cr₹2 Cr10.6%
Q1 FY26₹18 Cr₹2 Cr9.7%
Q4 FY25₹18 Cr₹2 Cr12.0%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Delivery averaged 69.6% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Sanjivani Paranteral Ltd.

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Products and Services

1. Manufacturing Pharmaceutical Products-This segment offers oral solids, parenterals, and sterile powder formulations. It also provides contract research and manufacturing services.

Business Segments

1. Pharmaceutical-100%

Sanjivani Paranteral Ltd. vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Sanjivani Paranteral Ltd.₹212 Cr31.114.76%₹19 Cr-18.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Sanjivani Paranteral Ltd.?

Sanjivani Paranteral Ltd. is trading at ₹171.20, with a market capitalisation of ₹212 Cr.

Which sector does Sanjivani Paranteral Ltd. belong to?

Sanjivani Paranteral Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Sanjivani Paranteral Ltd.?

Sanjivani Paranteral Ltd. has a P/E of 31.1 and a return on equity of 14.76%.

What is the stock symbol of Sanjivani Paranteral Ltd.?

Sanjivani Paranteral Ltd. is listed on the BSE under the scrip code 531569.

How has Sanjivani Paranteral Ltd.'s share price moved over the past year?

Sanjivani Paranteral Ltd.'s share price is down 18.0% over one year and down 10.6% over three months. Its 52-week range is ₹126.00 to ₹244.00.

What were Sanjivani Paranteral Ltd.'s latest quarterly results?

In Q1 FY27, Sanjivani Paranteral Ltd. reported revenue of ₹19 Cr and net profit of ₹2 Cr, with basic EPS of ₹1.87 (standalone, parsed from the company's exchange filing).

How have Sanjivani Paranteral Ltd.'s revenue and profit changed over the past year?

Sanjivani Paranteral Ltd. reported revenue of ₹19 Cr in Q1 FY27, up 8.8% from ₹18 Cr in Q1 FY26 and up 85.2% from ₹11 Cr in Q4 FY26.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.